Peptok
peptides profiled research articles
Sexual Health

Enclomiphene

Formula: C26H28ClNO

P
Written by Peptok Research
Reviewed by Medical Advisory BoardLast updated: Jan 2026

Quick Stats

Evidence Strength1/10 (Low)

Based on number and quality of indexed studies

Community Popularity3/10 (Low)

Based on search volume and community interest

Legal Status

⚖️ Not FDA-approved (FDA has rejected NDAs)

Type

Sexual Health

Route

Oral

Half-life

~10 hours

Medical Disclaimer

This content is for informational and research purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before making decisions about peptide use or any medical treatment. Individual results may vary.

Overview

Enclomiphene is a selective estrogen receptor modulator (SERM) primarily used to treat secondary hypogonadism in men. Unlike clomiphene, it isolates the active isomer, potentially leading to fewer side effects. Research suggests it can effectively boost testosterone levels and maintain fertility.

Quick Summary

  • 🧬
    What it is:Enclomiphene is a selective estrogen receptor modulator (SERM) primarily used to treat secondary hypogonadism in men.
  • 🎯
    Primary use:Sexual Health applications — see benefits section for details.
  • 📊
    Evidence level:Preliminary — Mostly anecdotal or very early-stage research (1 indexed papers)
  • Bottom line:Very early research phase. Approach with appropriate caution; long-term safety is unknown.

Enclomiphene stands out because it's one half of the more commonly known drug, clomiphene citrate. Clomiphene contains two isomers, zuclomiphene and enclomiphene, but enclomiphene is considered the more active component in stimulating testosterone production. The appeal of enclomiphene lies in the idea that isolating the "good" part of clomiphene may provide the benefits with a potentially reduced side effect profile.

While both drugs ultimately aim to increase testosterone, enclomiphene's focused approach has generated interest in the field of male hormone optimization. It's important to remember that while enclomiphene is sometimes considered a more refined version of clomiphene, both drugs require a prescription and careful monitoring by a healthcare professional. A study published in Translational Andrology and Urology (2024) directly compares the two drugs for hypogonadal men, highlighting the ongoing debate about which is superior.

How Enclomiphene Works

Enclomiphene works by acting as a selective estrogen receptor modulator (SERM). This means it binds to estrogen receptors in certain tissues, blocking estrogen's effects. In the brain, specifically the hypothalamus, enclomiphene blocks estrogen from signaling that there's enough testosterone in the body.

This estrogen blockade disrupts the normal feedback loop. The hypothalamus then releases more gonadotropin-releasing hormone (GnRH). GnRH then stimulates the pituitary gland to produce luteinizing hormone (LH) and follicle-stimulating hormone (FSH).

LH travels to the testicles and stimulates the Leydig cells to produce more testosterone. FSH supports sperm production (spermatogenesis). By increasing LH and FSH, enclomiphene indirectly boosts both testosterone levels and sperm count. This mechanism makes it a potential treatment for secondary hypogonadism, where the problem lies in the brain's signaling rather than the testicles themselves.

What the Research Actually Shows

Benefit: Increased Testosterone Levels

  • Study Type: Systematic review and meta-analysis
  • Findings: A 2023 study in Andrology analyzed obese men with androgen deficiency. The study showed that selective estrogen receptor modulation, the mechanism by which enclomiphene works, can improve testosterone levels.
  • Evidence Grade: Strong

Benefit: Maintaining Fertility

  • Study Type: Review Article
  • Findings: A 2019 review in Expert Review of Endocrinology & Metabolism suggests enclomiphene citrate can maintain fertility in men with secondary hypogonadism.
  • Evidence Grade: Moderate (review article, not original data)

Benefit: Sperm Count Improvement

  • Study Type: Retrospective Study
  • Findings: A 2023 retrospective study in Cureus compared clomiphene citrate and enclomiphene citrate for male infertility. While the study design has limitations, it suggests potential benefits for sperm count.
  • Evidence Grade: Preliminary (retrospective study)

Benefit: Safety Profile

  • Study Type: Clinical Trial
  • Findings: The 2024 study in Translational Andrology and Urology suggests that enclomiphene is a safe and effective option for hypogonadal men. The study directly compares enclomiphene to clomiphene, highlighting potential advantages in terms of side effects.
  • Evidence Grade: Moderate

Enclomiphene vs. Clomiphene

Enclomiphene and clomiphene are closely related, but understanding their differences is crucial. Clomiphene citrate is a mixture of two isomers: enclomiphene and zuclomiphene. Enclomiphene is believed to be the more active isomer, responsible for most of the desired effects on testosterone and sperm production. Zuclomiphene, on the other hand, has a longer half-life and may contribute more to side effects.

The key difference lies in the selectivity. Enclomiphene aims to isolate the beneficial effects of clomiphene by providing only the active isomer. The idea is that this could lead to a more predictable response and a reduced risk of side effects compared to taking the full clomiphene mixture.

From a mechanistic standpoint, both drugs ultimately work the same way: blocking estrogen receptors in the hypothalamus and stimulating increased testosterone production. However, the presence of zuclomiphene in clomiphene citrate adds a layer of complexity. Zuclomiphene's longer half-life means it stays in the body longer, potentially leading to prolonged estrogen receptor modulation and a higher chance of side effects. Some men may find they feel better on enclomiphene because they are not as sensitive to the effects of the ZU form of the drug.

The Honest Limitations

While enclomiphene shows promise, several limitations need to be considered. Much of the research is relatively recent, and longer-term studies are needed to fully assess its safety and efficacy.

Specifically, there's a need for more randomized controlled trials (RCTs) comparing enclomiphene to other treatments for hypogonadism, such as testosterone replacement therapy (TRT). While some studies compare enclomiphene to clomiphene, there's less data on how it stacks up against the gold standard of TRT in terms of symptom relief and overall quality of life.

Another limitation is the potential for side effects. While enclomiphene is often touted as having fewer side effects than clomiphene, this isn't definitively proven. As a SERM, it can still cause estrogen-related side effects like mood swings, nipple sensitivity, and visual disturbances. These side effects are not as common as with TRT, but should still be considered.

Finally, it's important to remember that enclomiphene is not a cure for hypogonadism. It addresses the hormonal imbalance by stimulating the body's own testosterone production, but it doesn't fix the underlying cause of the condition. If the reason for low testosterone is a problem with the pituitary gland or hypothalamus, enclomiphene may not be a long-term solution.

Timing is Key

Enclomiphene's half-life is around 10-12 hours. This means that the concentration of the drug in your body decreases by half every 10-12 hours. Because of this relatively short half-life, it's best to take enclomiphene at the same time each day to maintain stable blood levels. Consistency in timing can help optimize its effects and minimize potential fluctuations in hormone levels. Some people prefer to take it in the morning, while others find that taking it at night works better for them. Experiment to see what works best for you.

Benefits & Evidence

Stimulates natural testosterone production

Moderate Evidence

1 studies · 1 human trial

No estrogenic agonist side effects

Moderate Evidence

1 studies · 0 human trials

Preserves fertility

Preliminary

1 studies · 0 human trials

Oral administration

Preliminary

1 studies · 0 human trials

Better tolerated than clomiphene

Preliminary

1 studies · 0 human trials

Maintains LH/FSH axis

Preliminary

1 studies · 0 human trials

Who Uses Enclomiphene?

Athletes with injuries

Moderate

Accelerates tendon, ligament, and muscle repair

Post-surgery recovery

Preliminary

May improve wound healing and tissue regeneration

Chronic pain sufferers

Preliminary

Anti-inflammatory effects reported in animal studies

Active fitness enthusiasts

Anecdotal

Faster recovery between training sessions

Not recommended if:

Pregnant or nursing, history of hormone-sensitive cancers, active autoimmune conditions, or pediatric patients. Always consult a physician before starting any peptide protocol.

Dosage Guide

Protocol by Experience Level

ExperienceDoseFrequencyCycleRoute
Beginner13 mgDaily or EOD4–6 wks, 2 wks offOral
Intermediate19 mgDaily4–6 wks, 2 wks offOral
Advanced25 mgDaily (split dose)4–6 wks, 2 wks offOral

Standard Protocol

12.5-25 mg per day orally

Notes

Not yet FDA-approved as a standalone drug despite multiple Phase 3 trials. Available through some compounding pharmacies. Pure anti-estrogen without the pro-estrogen side effects of clomiphene (zuclomiphene). Not technically a peptide but commonly discussed in the peptide therapy ecosystem.

Route

Oral

Half-life

~10 hours

Molecular Weight

405.96 g/mol

Disclaimer

This information is for educational purposes only. Dosage information is derived from research literature and community reports. Always consult a qualified healthcare provider before using any peptide.

What the Community Reports

Community data coming soon

We're aggregating Reddit discussions for Enclomiphene.

Safety Profile

Regulatory Status

Not FDA-approved (FDA has rejected NDAs). Available through compounding pharmacies. Not a controlled substance.

Common

  • Headache
  • Hot flashes
  • Nausea

Rare

  • Mood changes
  • Visual disturbances (rare, less than clomiphene)

Serious

No serious adverse events reported in available literature.

Pregnancy: ❌ Not recommended — no safety dataKnown Interactions: 2 documented stacks
Available

Your Ad could be placed here.

Reach researchers and enthusiasts.

Contact Us

Research

Mechanism of Action

Enclomiphene competitively blocks estrogen receptors (ERα) in the hypothalamus and pituitary. Normally, estrogen provides negative feedback that suppresses GnRH, LH, and FSH production. By blocking this feedback, enclomiphene tricks the brain into thinking estrogen is low, causing increased GnRH pulsing, elevated LH/FSH, and consequently increased testicular testosterone production. Unlike zuclomiphene (the other isomer in Clomid), it has no estrogen agonist activity.

Search Volume Trend

Rank #8
12 months agoPresent

Common Stacks

Peptides frequently combined together for synergistic effects.

Gonadorelin

Cellular Energy

Cellular energy + peptide synergy for longevity protocols

Kisspeptin-10

Performance

Commonly combined with Kisspeptin-10 for enhanced outcomes

Peptok is editorially independent. Our research profiles are evidence-based and regularly updated. Sponsored content is always clearly labeled. Read our Editorial Policy.